Using RNA to interfere with a gene’s expression of disease-causing proteins is a validated therapeutic approach, but so far, the products in this drug class only address liver proteins. Reducing ...

Delivering therapies to the brain remains a major challenge due to the limited permeability of the blood-brain barrier. In a ...

SOUTH SAN FRANCISCO, Calif., Dec. 30, 2020 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc. (NASDAQ: VTGN), a biopharmaceutical company committed to developing a new generation of medicines with the ...

Praxis Precision Medicines will present late-stage epilepsy and movement disorder data at the AAN 2025 Annual Meeting in San Diego. Praxis Precision Medicines, Inc. announced its participation in the ...

(RTTNews) - Rapport Therapeutics, Inc. (RAPP), a clinical-stage biotechnology company focused on central nervous system disorders, on Thursday, announced promising results from its Phase 1 PET and MAD ...

Despite the fact that the central nervous system (CNS) disease treatment market accounts for nearly 20% of the overall therapeutics market and has significant unmet medical needs, the recent ...

Please provide your email address to receive an email when new articles are posted on . Meaningful progress is being made in the development of gene therapies for rare neurological diseases caused by ...

Alto Neuroscience (ANRO) is a biotech to watch, because it has a major catalyst that is approaching in the 2nd half of 2024. This would be with respect to its lead drug known as ALTO-100, which is ...

SAN DIEGO--(BUSINESS WIRE)--Autobahn Therapeutics is launching to create the next generation of regenerative medicines to restore hope for people affected by CNS disorders. The company has completed a ...

CAMBRIDGE, MA / ACCESS Newswire / April 6, 2025 / Sea Pharmaceuticals, LLC (Sea) today announced its selection of Inotiv Inc. (NASDAQ:NOTV) for pre-clinical development IND-enabling studies to support ...

The "Central Nervous System Therapeutics Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Central Nervous System Therapeutics was ...